Description: UCB Biosciences, Inc. is conducting a clinical trial to evaluate the effectiveness and safety of lacosamide (Vimpat®) in children less than 4 years of age who have partial-onset seizures.  There are study locations in Alabama, Florida, Louisiana, Nevada, New Hampshire, Ohio, Texas, and Washington. For more information contact Jo Anne Nakagawa at jnakagawa@tscalliance.org or 240-638-4654 for specific site location and study coordinator phone number.